Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV : Data from the ICONA cohort
Liver International · 2024
DOI: 10.1111/liv.15804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Antonella d'Arminio Monforte und 19 weiteren Autor:innen. Beteiligte Einrichtung: ICONA Foundation, Milan, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Coinfection, Drug Users, Liver Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Objectives
We aimed to study hepatitis D virus (HDV) prevalence and risk of progression to severe liver‐related events (SLRE) in HBsAg positive people living with HIV (PLWH) in Italy; role of HDV‐RNA copy levels, HCV coinfection and nadir CD4 counts were also investigated.
Methods
People living with HIV (PLWH) from Italian Foundation cohort Naïve antiretrovirals (ICONA) with available HBsAg and HDV Ab were enrolled. HBsAg, HDV Ab, HDV‐RNA and HDV genotypes were tested. Primary end‐point: time from first HDV screening to Severe Liver Related Events (SLRE: decompensated cirrhosis, liver transplantation, HCC). Fine‐grey regression models were used to evaluate the association of HDV Ab, HDV‐RNA, HDV/HCV coinfection, CD4 nadir and outcome. Secondary end‐points: time to SLRE or death; HDV Ab and HDV‐RNA prevalence.
Results
A total of 152/809 (18.8%) HBsAg positive PLWH showed HDV Ab reactivity; 63/93 (67.7%) were HDV‐RNA positive. Being male, persons who inject drugs (PWID), HCV Ab positive, with FIB‐4 > 3.25 were independent factors of HDV Ab positivity. In a median follow‐up of 5 years, 37 PLWH (4.1% at 5‐year) developed SLRE and 97 (12.0%) reached the SLRE or death end‐point. HDV‐RNA positive (independently from HDV‐RNA copy level) PLWH had a 4.6‐fold (95%CI 2.0–10.5) higher risk of SLRE than HDV negatives. PLWH positive for both HCV Ab and HDV Ab showed the highest independent risk of SLRE (ASHR: 11.9, 95%CI: 4.6–30.9 vs. HCV neg/HDV neg). Nadir CD4 < 200/mL was associated with SLRE (ASHR: 3.9, 95% 1.0–14.5).
Conclusions
One‐fifth of the HBsAg positive PLWH harbour HDV infection, and are at high risk of progression to advanced liver disease. HCV contributes to worse outcomes. This population needs urgently effective treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICONA Foundation, Milan, Italy.
- Department of Biology, University of Rome Tor Vergata, Rome, Italy.
- Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
- Unity of Microbiology and Biobank, INMI, Rome, Italy.
- Department of Medicine of Systems, University of Rome Tor Vergata, Rome, Italy.
- Clinical and Research Infectious Diseases Department, INMI, Rome, Italy.
ORCID-Profile: Vincenzo Malagnino, Roberto Rossotti, Francesca Ceccherini Silberstein
Förderung
- Gilead Sciences
Zitieren
APA
d'Arminio Monforte, A., Tavelli, A., Salpini, R., Piermatteo, L., D'Anna, S., Carrara, S., Malagnino, V., Mazzotta, V., Brancaccio, G., Marchetti, G. C., Rosselli Del Turco, E., Rossotti, R., Mussini, C., Antinori, A., Lo Caputo, S., Ceccherini Silberstein, F., Gaeta, G. B., Svicher, V., Puoti, M., & Icona Foundation Study Group (2024). Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV : Data from the ICONA cohort. Liver International. https://doi.org/10.1111/liv.15804
Vancouver
d'Arminio Monforte A, Tavelli A, Salpini R, Piermatteo L, D'Anna S, Carrara S, et al. Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV : Data from the ICONA cohort. Liver International. 2024. doi:10.1111/liv.15804
BibTeX
@article{dArminioMonforte2024,
author = {d'Arminio Monforte, Antonella and Tavelli, Alessandro and Salpini, Romina and Piermatteo, Lorenzo and D'Anna, Stefano and Carrara, Stefania and Malagnino, Vincenzo and Mazzotta, Valentina and Brancaccio, Giuseppina and Marchetti, Giulia Carla and Rosselli Del Turco, Elena and Rossotti, Roberto and Mussini, Cristina and Antinori, Andrea and Lo Caputo, Sergio and Ceccherini Silberstein, Francesca and Gaeta, Giovanni Battista and Svicher, Valentina and Puoti, Massimo and Icona Foundation Study Group, Icona Foundation Study Group},
title = {Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV : Data from the ICONA cohort},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.15804}
}
EUVIMED